In February, Epocrates announced plans to raise $75 million through an initital public offering of common stock.


For giving doctors and nurses instant drug reference

Your doctors may not have memorized dosage information, interactions, and side effects for every drug—but they don't need to, thanks to Epocrates's easy-to-use drug-reference program for mobiles and laptops. The program allows medical professionals to make smart prescribing decisions with the click of a button, and 45% of U.S. doctors have already signed on. "When they are in front of patients, they can get information in a split second," says Rose Crane, the company's CEO. Last year, Epocrates said that it's developing a platform to give doctors access to patients' electronic health records, supplying them with even more instant grist for making sound treatment recommendations.

Photograph by: Psyberartist

Add New Comment